跳至主要内容
临床试验/ACTRN12608000293369
ACTRN12608000293369尚未招募4 期

Intravenous Levetiracetam in the Acute Management of Seizures in Epilepsy

Prof. David C. Reutens0 个研究点目标入组 20 人开始时间: 2008年6月12日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Epilepsy patients admitted for pre-surgical work-up at Monash Medical Centre with occurrence of acute seizures during epilepsy monitoring

排除标准

  • Women who are pregnanat or are considering pregnancy, lactation, moderate to severe renal dysfunction

研究者

发起方
Prof. David C. Reutens

相似试验

进行中(未招募)
不适用
Prospective trial of intravenous levetiracetam in patients with primary brain tumors and at least one symptomatic seizure who undergo biopsy or cytoreductive surgery. - HELLO-StudyMedDRA version: 9.1Level: LLTClassification code 10015037Term: EpilepsyEpilepsy
EUCTR2007-005063-96-DEniversity Hospital Tübingen
尚未招募
不适用
Comparison of the safety, tolerability, and efficacy, of levetiracetam versus phenytoin when administered intravenously to an inpatient population at risk for seizures.SeizuresNeurological - Other neurological disorders
ACTRN12607000182493Professor Mark Cook80
进行中(未招募)
不适用
Efficacy and safety of Levetiracetam treatment in patients suffering from Restless Legs SyndromeEficacia y seguridad de un tratamiento con levetiracetam en pacientes con síndrome idiopático de piernas inquietasRestless legs syndrome (RLS)
EUCTR2005-001516-41-ESClínica Plató Fundació Privada12
进行中(未招募)
不适用
Efficacité du levetiracetam intra-veineux en association avec le clonazepam versus clonazepam seul dans la prise en charge pré-hospitalière de l'état de mal épileptique généralisé tonico-clonique - SAMUKEPPRAPatient faisant un EMTC et pris en charge par une équipe du SMURMedDRA version: 8.1Level: PTClassification code 10018664Term: Grand mal status, epileptic
EUCTR2007-005782-35-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
进行中(未招募)
1 期
Efficacy and safety of levetiracetam in the inpatient treatment of alcohol withdrawal syndrome[Sicherheit und Wirksamkeit von Levetiracetam (Keppra) für die Behandlung des stationären Alkoholentzugsyndroms] - Keppra 1alcohol withdrawal syndrome (AWS) in inpatients
EUCTR2005-001486-33-DECharité Campus Mitte, Klinik für Psychiatrie und Psychotherapie120